These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17319790)

  • 21. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
    Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
    Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
    Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
    Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
    Zúbor P; Vojvodová A; Danko J; Kajo K; Szunyogh N; Lasabová Z; Biringer K; Visnovský J; Dókus K; Galajda P; Plank L
    Neoplasma; 2006; 53(1):49-55. PubMed ID: 16416013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
    Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
    Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
    Tommiska J; Eerola H; Heinonen M; Salonen L; Kaare M; Tallila J; Ristimäki A; von Smitten K; Aittomäki K; Heikkilä P; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2005 Jul; 11(14):5098-103. PubMed ID: 16033823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study.
    Rohan TE; Li SQ; Hartwick R; Kandel RA
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1316-23. PubMed ID: 16835330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 haplotype determination in breast cancer.
    Weston A; Pan CF; Ksieski HB; Wallenstein S; Berkowitz GS; Tartter PI; Bleiweiss IJ; Brower ST; Senie RT; Wolff MS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):105-12. PubMed ID: 9037561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
    Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece.
    Kalemi TG; Lambropoulos AF; Gueorguiev M; Chrisafi S; Papazisis KT; Kotsis A
    Cancer Lett; 2005 May; 222(1):57-65. PubMed ID: 15837541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the polymorphisms in the exons 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population.
    Fernandes TA; Lima GL; De Souza FC; Fernandes JV; Meissner RV
    Cell Mol Biol (Noisy-le-grand); 2008 Jun; 54 Suppl():OL1025-31. PubMed ID: 18954551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study.
    He XF; Su J; Zhang Y; Huang X; Liu Y; Ding DP; Wang W; Arparkorn K
    Breast Cancer Res Treat; 2011 Nov; 130(2):517-29. PubMed ID: 21604156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans.
    Gu J; Wu X; Dong Q; Romeo MJ; Lin X; Gutkind JS; Berman DM
    Cancer; 2006 Jun; 106(12):2716-24. PubMed ID: 16691626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
    Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
    Papadakis EN; Dokianakis DN; Spandidos DA
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50.
    Wang-Gohrke S; Chang-Claude J; Becher H; Kieback DG; Runnebaum IB
    Cancer Res; 2000 May; 60(9):2348-50. PubMed ID: 10811106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D receptor gene polymorphisms and breast cancer risk.
    Guy M; Lowe LC; Bretherton-Watt D; Mansi JL; Peckitt C; Bliss J; Wilson RG; Thomas V; Colston KW
    Clin Cancer Res; 2004 Aug; 10(16):5472-81. PubMed ID: 15328186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.